2024
BrosMed receives FDA 510(k) clearance of the Tri-Wedge PTA Scoring Balloon Catheter
2024-10-24

BrosMed receives FDA 510(k) clearance of the Tri-Wedge PTA Scoring Balloon Catheter

BrosMed Medical Co., Ltd. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Tri-Wedge PTA Scoring Balloon Dilatation Catheter. “This represents yet another significant achievement in our effort to introduce BrosMed’s broad portfolio into the US market”, comments Scott J. Addonizio, Chief Operating Officer.
BrosMed Medical Achieves CE Certification for Mars and Mars NC PTCA Balloon Dilatation Catheters Under EU MDR Regulations
2024-10-08

BrosMed Medical Achieves CE Certification for Mars and Mars NC PTCA Balloon Dilatation Catheters Under EU MDR Regulations

Sept. 30th, 2024 – BROSMED, an industry-leading multinational group in […]
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024-08-01

BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer

2024 August 1st – BrosMed Medical is pleased to announce […]
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
2024-05-27

BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters

BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).